Effect of exercise and osteochondral injury on synovial fluid and serum concentrations of carboxy-terminal telopeptide fragments of type II collagen in racehorses

American Journal of Veterinary Research

Volumn 71, Issue 1, 2010, Pages 33-40

  Cleary, Orlaith B ^a   Trumble, Troy N ^b   Merritt, Kelly A ^a   Brown, Murray P ^a  

^a University of Florida   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 2;

ARTHROSCOPY; ARTICLE; CARPAL JOINT; CARTILAGE DEGENERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE; HORSE; INJURY SEVERITY; JOINT INJURY; JOINT RADIOGRAPHY; METACARPOPHALANGEAL JOINT; NONHUMAN; OSTEOCHONDRAL INJURY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SYNOVIAL FLUID;

ANIMALS; ARTHROSCOPY; BIOLOGICAL MARKERS; CARTILAGE, ARTICULAR; COLLAGEN TYPE II; HORSE DISEASES; HORSES; JOINT DISEASES; PHYSICAL CONDITIONING, ANIMAL; RUNNING; SYNOVIAL FLUID;

ANIMALIA; CONGIOPODIDAE; EQUIDAE;

EID: 75749158553     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.71.1.33     Document Type: Article

References (48)

1. Eyre D. Collagen of articular cartilage. Arthritis Res 2002;4:30-35.
2. Hardingham TE, Fosang AJ, Dudhia J. The structure, function and turnover of aggrecan, the large aggregating proteoglycan from cartilage. Eur J Clin Chem Clin Biochem 1994;32:249-257.
3. Dejica VM, Mort JS, Laverty S, et al. Cleavage of type II collagen by cathepsin K in human osteoarthritic cartilage. Am J Pathol 2008;173:161-169.
4. Karsdal MA, Madsen SH, Christiansen C, et al. Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity. Arthritis Res Ther 2008;10: R63.
5. Sondergaard BC, Henriksen K, Wulf H, et al. Relative contribution of matrix metalloprotease and cysteine protease activities to cytokine-stimulated articular cartilage degradation. Osteoarthritis Cartilage 2006;14:738-748.
6. Zhen EY, Brittain IJ, Laska DA, et al. Characterization of metalloprotease cleavage products of human articular cartilage. Arthritis Rheum 2008;58:2420-2431.
7. Lohmander LS, Atley LM, Pietka TA, et al. The release of cross-linked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis. Arthritis Rheum 2003;48:3130-3139.
8. Sandell L, Heinegard D, Hering T. Cell biology, biochemistry, and molecular biology of articular cartilage in osteoarthritis. In: Seibel MJ, Robins SP, Bilezikian JP, eds. Dynamics of bone and cartilage metabolism: principles and clinical applications. 2nd ed. San Diego: Academic Press Inc. 2006;73-98.
9. Vinardell T, Dejica V, Poole AR, et al. Evidence to suggest that cathepsin K degrades articular cartilage in naturally occurring equine osteoarthritis. Osteoarthritis Cartilage 2009;17:375-383.
10. O'Kane JW, Hutchinson E, Atley LM, et al. Sport-related differences in biomarkers of bone resorption and cartilage degradation in endurance athletes. Osteoarthritis Cartilage 2006;14:71-76.
11. Brama PA, Tekoppele JM, Bank RA, et al. The influence of strenuous exercise on collagen characteristics of articular cartilage in Thoroughbreds age 2 years. Equine Vet J 2000;32:551-554.
12. Frisbie DD, Al-Sobayil F, Billinghurst RC, et al. Changes in synovial fluid and serum biomarkers with exercise and early osteoarthritis in horses. Osteoarthritis Cartilage 2008;16:1196-1204.
13. Christgau S, Garnero P, Fledelius C, et al. Collagen type II C-telopeptide fragments as an index of cartilage degradation. Bone 2001;29:209-215.
14. Ishikawa T, Nishigaki F, Christgau S, et al. Cartilage destruction in collagen induced arthritis assessed with a new biochemical marker for collagen type H C-telopeptide fragments. J Rheumatol 2004;31:1174-1179.
15. Oestergaard S, Chouinard L, Doyle N, et al. The utility of measuring C-terminal telopeptides of collagen type II (CTX-II) in serum and synovial fluid samples for estimation of articular cartilage status in experimental models of destructive joint diseases. Osteoarthritis Cartilage 2006;14:670-679.
16. Oestergaard S, Chouinard L, Doyle N, et al. Early elevation in circulating levels of C-telopeptides of type II collagen predicts structural damage in articular cartilage in the rodent model of collagen-induced arthritis. Arthritis Rheum 2006;54:2886-2890.
17. Oestergaard S, Rasmussen KE, Doyle N, et al. Evaluation of cartilage and bone degradation in a murine collagen antibody-induced arthritis model. Scand J Immunol 2008;67:304-312.
18. Nielsen RH, Christiansen C, Stolina M, et al. Oestrogen exhibits type II collagen protective effects and attenuates collagen-induced arthritis in rats. Clin Exp Immunol 2008;152:21-27.
19. Bay-Jensen AC, Andersen TL, Chami-Ben Tabassi N, et al. Biochemical markers of type II collagen breakdown and synthesis are positioned at specific sites in human osteoarthritic knee cartilage. Osteoarthritis Cartilage 2008;16:615-623.
20. Hoegh-Andersen P, Tankâo LB, Andersen TL, et al. Ovariectomized rats as a model of postmenopausal osteoarthritis: validation and application. Arthritis Res Ther 2004;6:R169-R180.
21. Garnero P, Conrozier T, Christgau S, et al. Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis. Ann Rheum Dis 2003;62:939-943.
22. Garnero P, Mazieres B, Gueguen A, et al. Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity and radiological joint damage in patients with hip osteoarthritis: the ECHODIAH cohort. J Rheumatol 2005;32:697-703.
23. Gamero P, Piperno M, Gineyts E, et al. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis 2001;60:619-626.
24. Jordan KM, Syddall HE, Garnero P, et al. Urinary CTX-II and glucosyl-galactosyl-pyridinoline are associated with the presence and severity of radiographic knee osteoarthritis in men. Ann Rheum Dis 2006;65:871-877.
25. Garnero P, Ayral X, Rousseau JC, et al. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Arthritis Rheum 2002;46:2613-2624.
26. Bruyere O, Collette J, Kothari M, et al. Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study. Ann Rheum Dis 2006;65:1050-1054.
27. Conaghan PG, Felson D, Gold G, et al. MRI and non-cartilaginous structures in knee osteoarthritis. Osteoarthritis Cartilage 2006;14(suppl A):A87-A94.
28. Dam EB, Byrjalsen I, Karsdal MA, et al. Increased urinary excretion of C-telopeptides of type II collagen (CTX-H) predicts cartilage loss over 21 months by MRI. Osteoarthritis Cartilage 2009;17:384-389.
29. Garnero P, Peterfy C, Zaim S, et al. Bone marrow abnormalities on magnetic resonance imaging are associated with type U collagen degradation in knee osteoarthritis: a three-month longitudinal study. Arthritis Rheum 2005;52:2822-2829.
30. Garnero P, Aronstein WS, Cohen SB, et al. Relationships between biochemical markers of bone and cartilage degradation witb radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial. Osteoarthritis Cartilage 2008;16:660-666.
31. Manicourt DH, Bevilacqua M, Righini V, et al. Comparative effect of nimesulide and ibuprofen on the urinary levels of col-lagen type II C-telopeptide degradation products and on the serum levels of hyaluronan and matrix metalloproteinases-3 and -13 in patients with flare-up of osteoarthritis. Drugs R D 2005;6:261-271.
32. Sondergaard BC, Wulf H, Henriksen K, et al. Calcitonin directly attenuates collagen type II degradation by inhibition of matrix metalloproteinase expression and activity in articular chondrocytes. Osteoarthritis Cartilage 2006;14:759-768.
33. Richardson DW, Dodge GR. Cloning of equine type II procollagen and the modulation of its expression in cultured equine articular chondrocytes. Matrix Biol 1997;16:59-64.
34. Brown MP, Trumble TN, Plaas AH, et al. Exercise and injury increase chondroitin sulfate chain length and decrease hyaluronan chain length in synovial fluid. Osteoarthritis Cartilage 2007;15:1318-1325.
35. Fuller CJ, Barr AR, Sharif M, et al. Cross-sectional comparison of synovial fluid biochemical markers in equine osteoarthritis and the correlation of these markers with articular cartilage damage. Osteoarthritis Cartilage 2001;9:49-55.
36. Trumble TN, Brown MP, Merritt KA, et al. Joint dependent concentrations of bone alkaline phosphatase in serum and synovial fluids of horses with osteochondral injury: an analytical and clinical validation. Osteoarthritis Cartilage 2008;16:779-786.
37. Trumble TN, Scarbrough AB, Brown MP. Osteochondral injury increases type II collagen degradation products (C2C) in synovial fluid of Thoroughbred racehorses. Osteoarthritis Cartilage 2009;17:371-374.
38. Mwale F, Tchetina E, Wu CW, et al. The assembly and remodeling of the extracellular matrix in the growth plate in relationship to mineral deposition and cellular hypertrophy: an in situ study of collagens II and IX and proteoglycan. J Bone Miner Res 2002;17:275-283.
39. Getty R. Equine osteology. In: Getty R, ed. Sisson and Grossman's the anatomy of the domestic animals. 5th ed. Philadelphia: WB Saunders Co, 1975;255-348.
40. Salisbury C, Sharif M. Relations between synovial fluid and serum concentrations of osteocalcin and other markers of joint tissue turnover in the knee joint compared with peripheral blood. Ann Rheum Dis 1997;56:558-561.
41. Lohmander LS, Saxne T, Heinegard D. Increased concentrations of bone sialoprotein in joint fluid after knee injury. Ann Rheum Dis 1996;55:622-626.
42. Palmer J, Bertone A. Joint biomechanics in the pathogenesis of traumatic arthritis. In: McIlwraith C, Trotter G, eds. Joint disease in the horse. Philadelphia: WB Saunders Co, 1996;104-119.
43. Fuller CJ, Barr AR, Dieppe PA. Variations in cartilage catabolism in different equine joints in response to interleukin-1 in vitro. Vet Rec 2001;148:204-206.
44. Fuller CJ, Barr AR, Dieppe PA, et al. Variation of an epitope of keratan sulphate and total glycosaminoglycans in normal equine joints. Equine Vet J 1996;28:490-493.
45. Cole A, Hauselmann H, Flechtenmacher J, et al. Metabolic difference between knee and ankle. In: Hascall VC, Kuettner KE, eds. The many faces of osteoarthritis. Boston: Birkhauser, 2002;27-29.
46. Frisbie DD, Ray CS, Ionescu M, et al. Measurement of synovial fluid and serum concentrations of the 846 epitope of chondroitin sulfate and of carboxy propeptides of type II procollagen for diagnosis of osteochondral fragmentation in horses. Am J Vet Res 1999;60:306-309.
47. Oakley SP, Portek I, Szomor Z. Arthroscopy - a potential "gold standard" for the diagnosis of the chondropathy of early osteoarthritis. Osteoarthritis Cartilage 2005;13:368-378.
48. Fradette ME, Céleste C, Richard H, et al. Effects of continuous oral administration of phenylbutazone on biomarkers of cartilage and bone metabolism in horses. Am J Vet Res 2007;68:128-133.